IL24 and infection: This results in profound anticancer activity, which is greater than the observed following infection with a non-replication adenovirus expressing mda-7/IL-24, in vitro in established cancer cell lines, primary cancer-derived tumor cells, and patient-derived human PDX tumor cells [44,45,58,59,60].